Subject-by-Formulation Interaction is a variance component in the statistical analysis of bioequivalence studies that captures the differential response of individual subjects to different drug formulations, indicating whether the magnitude of treatment effect varies significantly across subjects.
17
Publications
833
Citations
40
Authors
22
Institutions
Publications per year
2017–2026
1
Publications
17
An individual bioequivalence criterion: regulatory considerations
Mei‐Ling Chen, Rabindra Patnaik, Walter W. Hauck et al. · Statistics in Medicine · 2000 · 61 citations
1–5 of 17
Authors
40
- RPRabindra Patnaik
Center for Drug Evaluation and Research, United States
2 publications · 104 citations
2
h-index
- TH
2
h-index
- LT
2
h-index
- WW
2
h-index
- LE
2
h-index
1–5 of 40
Institutions
22
Center for Drug Evaluation and Research
Silver Spring, United States
2 h-index
9 publications
495 citations
Semmelweis University
Budapest, Hungary
2 h-index
2 publications
48 citations
University of Toronto
Toronto, Canada
2 h-index
3 publications
76 citations
University at Buffalo, State University of New York
Buffalo, United States
1 h-index
1 publications
17 citations
Abbott (United Kingdom)
Maidenhead, United Kingdom
1 h-index
1 publications
12 citations
Thomas Jefferson University
Philadelphia, United States
1 h-index
2 publications
86 citations
Colorado State University
Fort Collins, United States
1 h-index
2 publications
38 citations
Nanjing General Hospital of Nanjing Military Command
Nanjing, China
1 h-index
1 publications
206 citations
1–8 of 22
Venues
- Biometrics
3 publications · 145 citations
3
h-index
- Statistics in Medicine
3 publications · 108 citations
3
h-index
- Pharmaceutical Research
2 publications · 63 citations
2
h-index
- Journal of Pharmacokinetics and Pharmacodynamics
1 publications · 17 citations
1
h-index
- Clinical Therapeutics
1 publications · 14 citations
1
h-index
1–5